Skip to main content

Table 3 Studies reporting the relationship between frailty and thirty-day mortality patients undergoing surgery for colorectal cancer

From: The prevalence and prognostic value of frailty screening measures in patients undergoing surgery for colorectal cancer: observations from a systematic review

Study

Design

Patient (n =)

Country

Frailty screening tool

Frailty Prevalence

Timing of assessment

Age (Median/ Mean; years)

% Male/Female

TNM Stage

Comments

Artiles-Armas et al. (2021,) [34]

Prospective

149

Spain

Clinical Frailty Scale

42 (CSHA CFS ≥ 4)

Pre-operative

75

64/36

I-IV

Frailty associated with increased mortality on UV analysis

(P = 0.009)

Miller et al. (2020,) [26]

Retrospective

9,252

USA

Modified Frailty Index (MFI-5)

15 (MFI ≥ 2)

Pre-operative

NR (25% ≥ 65)

58/42

I-IV

Frailty associated with increased mortality on MV binary log regression

(OR 20.8, 95% CI 6.2–70.0, P < 0.001)

Reisinger et al. (2015,) [28]

Retrospective

340

Netherlands

Groningen Frailty Indicator

25 (GFI ≥ 5)

Pre-operative

69

50/50

II-IV

Frailty not associated with increased mortality on UV binary log regression

(P = 0.72)

Souwer et al. (2018,) [30]

Retrospective

139

Netherlands

Geriatric 8 questionnaire

50 (G8 ≤ 14)

Pre-operative

77.8

55/45

I-III

Frailty not associated with increased mortality on UV binary log regression

(P = 1.00)

  1. UV Univariate, MV Multivariate, OR Odds Ratio